Ladenburg Thalmann Financial Services’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-30
Closed 5117
2017
Q1
$0 Sell
30
-142
-83% -$184 ﹤0.01% 5100
2016
Q4
$0 Buy
172
+30
+21% +$55 ﹤0.01% 5065
2016
Q3
$0 Hold
142
﹤0.01% 4980
2016
Q2
$0 Hold
142
﹤0.01% 4955
2016
Q1
$0 Sell
142
-2
-1% -$4 ﹤0.01% 4942
2015
Q4
$0 Hold
144
﹤0.01% 4890
2015
Q3
$1K Hold
144
﹤0.01% 4534
2015
Q2
$1K Sell
144
-214
-60% -$3K ﹤0.01% 4596
2015
Q1
$6K Hold
358
﹤0.01% 3929
2014
Q4
$6K Hold
358
﹤0.01% 3696
2014
Q3
$9K Buy
358
+143
+67% +$3.45K ﹤0.01% 3186
2014
Q2
$5K Hold
215
﹤0.01% 3413
2014
Q1
$6K Sell
215
-2
-0.9% -$67 ﹤0.01% 3223
2013
Q4
$7K Hold
217
﹤0.01% 3135
2013
Q3
$6K Buy
217
+1
+0.5% +$24 ﹤0.01% 3122
2013
Q2
$5K Buy
+216
New +$5.32K ﹤0.01% 3087

Other funds holding WINT

Ladenburg Thalmann Financial Services's WINT Position: Q2 2017 in Review

Ladenburg Thalmann Financial Services sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 30 shares.

Ladenburg Thalmann Financial Services first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $9K in Q3 2014. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 30 Windtree Therapeutics Inc shares in Q2 2017.
  • Ladenburg Thalmann Financial Services first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Ladenburg Thalmann Financial Services's Windtree Therapeutics Inc position peaked at $9K in Q3 2014.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2017, filed 14 Aug 2017.